Baidu
map
CANCER BIOMARK 润色咨询

Cancer Biomarkers

出版年份：2005 年文章数：1193 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：2.1% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：预后指标;肝癌预后<br>经验分享：2023.3.18 submission---under review<br>2023.4.21 major revise 8条 minor revise 3条（纯临床研究，虽然问题多，但都比较好回答，没有让我补充数据）<br>2023.5.08 resubmission---under review<br>2023.5.23 under review---process in decision<br>2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤<br>经验分享：属实非常慢的杂志了，8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：强烈劝退，审稿9个月，review意见回来应该是1个拒稿2个大修，1个月后编辑拒稿，理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向：肿瘤标志物<br>经验分享：投了将近一个月，现在状态是under review是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号<span class="quote">闪电下课 2019-08-04 发表::<br>投稿后一般多久会给稿号啊，现在想看看状态都看不了</span><span class="quote">闪电下课 2019-08-04 16:38:00 发表:<br>投稿后一般多久会给稿号啊，现在想看看状态都看不了</span>, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：从提交到一审意见回来经历了4个多月，四个审稿人，两个小修两个大修，结果编辑给的意见是拒稿，说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向： 肿瘤 <br>经验分享：3月26后投稿，6月15日小修，6月26日修回，7月18号接收，感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2023-05-29 ms3000000907122076 来自广西

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向：预后指标;肝癌预后
    经验分享：2023.3.18 submission---under review
    2023.4.21 major revise 8条 minor revise 3条（纯临床研究，虽然问题多，但都比较好回答，没有让我补充数据）
    2023.5.08 resubmission---under review
    2023.5.23 under review---process in decision
    2023.5.28 accept

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：预后指标;肝癌预后<br>经验分享：2023.3.18 submission---under review<br>2023.4.21 major revise 8条 minor revise 3条（纯临床研究，虽然问题多，但都比较好回答，没有让我补充数据）<br>2023.5.08 resubmission---under review<br>2023.5.23 under review---process in decision<br>2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤<br>经验分享：属实非常慢的杂志了，8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：强烈劝退，审稿9个月，review意见回来应该是1个拒稿2个大修，1个月后编辑拒稿，理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向：肿瘤标志物<br>经验分享：投了将近一个月，现在状态是under review是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号<span class="quote">闪电下课 2019-08-04 发表::<br>投稿后一般多久会给稿号啊，现在想看看状态都看不了</span><span class="quote">闪电下课 2019-08-04 16:38:00 发表:<br>投稿后一般多久会给稿号啊，现在想看看状态都看不了</span>, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：从提交到一审意见回来经历了4个多月，四个审稿人，两个小修两个大修，结果编辑给的意见是拒稿，说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向： 肿瘤 <br>经验分享：3月26后投稿，6月15日小修，6月26日修回，7月18号接收，感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2023-04-05 jiarong 来自湖南省

    审稿速度:12.0 | 投稿命中率:75.0
    偏重的研究方向：肿瘤
    经验分享：属实非常慢的杂志了，8个月到1年起吧

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：预后指标;肝癌预后<br>经验分享：2023.3.18 submission---under review<br>2023.4.21 major revise 8条 minor revise 3条（纯临床研究，虽然问题多，但都比较好回答，没有让我补充数据）<br>2023.5.08 resubmission---under review<br>2023.5.23 under review---process in decision<br>2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤<br>经验分享：属实非常慢的杂志了，8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：强烈劝退，审稿9个月，review意见回来应该是1个拒稿2个大修，1个月后编辑拒稿，理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向：肿瘤标志物<br>经验分享：投了将近一个月，现在状态是under review是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号<span class="quote">闪电下课 2019-08-04 发表::<br>投稿后一般多久会给稿号啊，现在想看看状态都看不了</span><span class="quote">闪电下课 2019-08-04 16:38:00 发表:<br>投稿后一般多久会给稿号啊，现在想看看状态都看不了</span>, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：从提交到一审意见回来经历了4个多月，四个审稿人，两个小修两个大修，结果编辑给的意见是拒稿，说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向： 肿瘤 <br>经验分享：3月26后投稿，6月15日小修，6月26日修回，7月18号接收，感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2022-08-24 YC1025

    审稿速度:12.0 | 投稿命中率:50.0
    经验分享：强烈劝退，审稿9个月，review意见回来应该是1个拒稿2个大修，1个月后编辑拒稿，理由非常不专业

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：预后指标;肝癌预后<br>经验分享：2023.3.18 submission---under review<br>2023.4.21 major revise 8条 minor revise 3条（纯临床研究，虽然问题多，但都比较好回答，没有让我补充数据）<br>2023.5.08 resubmission---under review<br>2023.5.23 under review---process in decision<br>2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤<br>经验分享：属实非常慢的杂志了，8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：强烈劝退，审稿9个月，review意见回来应该是1个拒稿2个大修，1个月后编辑拒稿，理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向：肿瘤标志物<br>经验分享：投了将近一个月，现在状态是under review是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号<span class="quote">闪电下课 2019-08-04 发表::<br>投稿后一般多久会给稿号啊，现在想看看状态都看不了</span><span class="quote">闪电下课 2019-08-04 16:38:00 发表:<br>投稿后一般多久会给稿号啊，现在想看看状态都看不了</span>, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：从提交到一审意见回来经历了4个多月，四个审稿人，两个小修两个大修，结果编辑给的意见是拒稿，说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向： 肿瘤 <br>经验分享：3月26后投稿，6月15日小修，6月26日修回，7月18号接收，感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2022-06-20 ms8000001241612634

    偏重的研究方向：肿瘤标志物
    经验分享：投了将近一个月，现在状态是under review是什么意思？

    5

    展开5条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：预后指标;肝癌预后<br>经验分享：2023.3.18 submission---under review<br>2023.4.21 major revise 8条 minor revise 3条（纯临床研究，虽然问题多，但都比较好回答，没有让我补充数据）<br>2023.5.08 resubmission---under review<br>2023.5.23 under review---process in decision<br>2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤<br>经验分享：属实非常慢的杂志了，8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：强烈劝退，审稿9个月，review意见回来应该是1个拒稿2个大修，1个月后编辑拒稿，理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向：肿瘤标志物<br>经验分享：投了将近一个月，现在状态是under review是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号<span class="quote">闪电下课 2019-08-04 发表::<br>投稿后一般多久会给稿号啊，现在想看看状态都看不了</span><span class="quote">闪电下课 2019-08-04 16:38:00 发表:<br>投稿后一般多久会给稿号啊，现在想看看状态都看不了</span>, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：从提交到一审意见回来经历了4个多月，四个审稿人，两个小修两个大修，结果编辑给的意见是拒稿，说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向： 肿瘤 <br>经验分享：3月26后投稿，6月15日小修，6月26日修回，7月18号接收，感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2020-02-04 Liuying11

    我的一天就给了稿号闪电下课 2019-08-04 发表::
    投稿后一般多久会给稿号啊，现在想看看状态都看不了    闪电下课 2019-08-04 16:38:00 发表:
    投稿后一般多久会给稿号啊，现在想看看状态都看不了

    闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：预后指标;肝癌预后<br>经验分享：2023.3.18 submission---under review<br>2023.4.21 major revise 8条 minor revise 3条（纯临床研究，虽然问题多，但都比较好回答，没有让我补充数据）<br>2023.5.08 resubmission---under review<br>2023.5.23 under review---process in decision<br>2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤<br>经验分享：属实非常慢的杂志了，8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：强烈劝退，审稿9个月，review意见回来应该是1个拒稿2个大修，1个月后编辑拒稿，理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向：肿瘤标志物<br>经验分享：投了将近一个月，现在状态是under review是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号<span class="quote">闪电下课 2019-08-04 发表::<br>投稿后一般多久会给稿号啊，现在想看看状态都看不了</span><span class="quote">闪电下课 2019-08-04 16:38:00 发表:<br>投稿后一般多久会给稿号啊，现在想看看状态都看不了</span>, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：从提交到一审意见回来经历了4个多月，四个审稿人，两个小修两个大修，结果编辑给的意见是拒稿，说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向： 肿瘤 <br>经验分享：3月26后投稿，6月15日小修，6月26日修回，7月18号接收，感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2021-12-28 学医的彭于晏

    什么时候需要highlights部分？

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：预后指标;肝癌预后<br>经验分享：2023.3.18 submission---under review<br>2023.4.21 major revise 8条 minor revise 3条（纯临床研究，虽然问题多，但都比较好回答，没有让我补充数据）<br>2023.5.08 resubmission---under review<br>2023.5.23 under review---process in decision<br>2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤<br>经验分享：属实非常慢的杂志了，8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：强烈劝退，审稿9个月，review意见回来应该是1个拒稿2个大修，1个月后编辑拒稿，理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向：肿瘤标志物<br>经验分享：投了将近一个月，现在状态是under review是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号<span class="quote">闪电下课 2019-08-04 发表::<br>投稿后一般多久会给稿号啊，现在想看看状态都看不了</span><span class="quote">闪电下课 2019-08-04 16:38:00 发表:<br>投稿后一般多久会给稿号啊，现在想看看状态都看不了</span>, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：从提交到一审意见回来经历了4个多月，四个审稿人，两个小修两个大修，结果编辑给的意见是拒稿，说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向： 肿瘤 <br>经验分享：3月26后投稿，6月15日小修，6月26日修回，7月18号接收，感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2021-12-28 乌云背后的幸福线

    highlights部分的一般要求是什么？

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：预后指标;肝癌预后<br>经验分享：2023.3.18 submission---under review<br>2023.4.21 major revise 8条 minor revise 3条（纯临床研究，虽然问题多，但都比较好回答，没有让我补充数据）<br>2023.5.08 resubmission---under review<br>2023.5.23 under review---process in decision<br>2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤<br>经验分享：属实非常慢的杂志了，8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：强烈劝退，审稿9个月，review意见回来应该是1个拒稿2个大修，1个月后编辑拒稿，理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向：肿瘤标志物<br>经验分享：投了将近一个月，现在状态是under review是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号<span class="quote">闪电下课 2019-08-04 发表::<br>投稿后一般多久会给稿号啊，现在想看看状态都看不了</span><span class="quote">闪电下课 2019-08-04 16:38:00 发表:<br>投稿后一般多久会给稿号啊，现在想看看状态都看不了</span>, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：从提交到一审意见回来经历了4个多月，四个审稿人，两个小修两个大修，结果编辑给的意见是拒稿，说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向： 肿瘤 <br>经验分享：3月26后投稿，6月15日小修，6月26日修回，7月18号接收，感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2021-07-24 ms6000001325372637

    审稿速度:6.0
    偏重的研究方向：肿瘤
    经验分享：从提交到一审意见回来经历了4个多月，四个审稿人，两个小修两个大修，结果编辑给的意见是拒稿，说我按照意见修改好之后欢迎我再重投。。。

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：预后指标;肝癌预后<br>经验分享：2023.3.18 submission---under review<br>2023.4.21 major revise 8条 minor revise 3条（纯临床研究，虽然问题多，但都比较好回答，没有让我补充数据）<br>2023.5.08 resubmission---under review<br>2023.5.23 under review---process in decision<br>2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤<br>经验分享：属实非常慢的杂志了，8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：强烈劝退，审稿9个月，review意见回来应该是1个拒稿2个大修，1个月后编辑拒稿，理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向：肿瘤标志物<br>经验分享：投了将近一个月，现在状态是under review是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号<span class="quote">闪电下课 2019-08-04 发表::<br>投稿后一般多久会给稿号啊，现在想看看状态都看不了</span><span class="quote">闪电下课 2019-08-04 16:38:00 发表:<br>投稿后一般多久会给稿号啊，现在想看看状态都看不了</span>, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：从提交到一审意见回来经历了4个多月，四个审稿人，两个小修两个大修，结果编辑给的意见是拒稿，说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向： 肿瘤 <br>经验分享：3月26后投稿，6月15日小修，6月26日修回，7月18号接收，感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2021-05-28 ms1000000930252947

    请问单基因的生信无验证可以投吗

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2139731, encodeId=34a82139e31c0, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：预后指标;肝癌预后<br>经验分享：2023.3.18 submission---under review<br>2023.4.21 major revise 8条 minor revise 3条（纯临床研究，虽然问题多，但都比较好回答，没有让我补充数据）<br>2023.5.08 resubmission---under review<br>2023.5.23 under review---process in decision<br>2023.5.28 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32418460254, createdName=ms3000000907122076, createdTime=Mon May 29 17:36:05 CST 2023, time=2023-05-29, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2123860, encodeId=76942123860b2, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向：肿瘤<br>经验分享：属实非常慢的杂志了，8个月到1年起吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d44d5556847, createdName=jiarong, createdTime=Wed Apr 05 10:34:27 CST 2023, time=2023-04-05, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1240727, encodeId=61841240e27d3, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：强烈劝退，审稿9个月，review意见回来应该是1个拒稿2个大修，1个月后编辑拒稿，理由非常不专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKpLKIqbhIAYYwoicribTG8OHGnwdK7m0DiayNiaYmcFCyibfj4nlXpBtlvehmq31ibtzU6DP3UH2Xibic2Rg/132, createdBy=20412361173, createdName=YC1025, createdTime=Wed Aug 24 16:02:07 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227578, encodeId=6406122e578d0, content=偏重的研究方向：肿瘤标志物<br>经验分享：投了将近一个月，现在状态是under review是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6ee6573401, createdName=ms8000001241612634, createdTime=Mon Jun 20 17:47:06 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584255, encodeId=c33458425541, content=我的一天就给了稿号<span class="quote">闪电下课 2019-08-04 发表::<br>投稿后一般多久会给稿号啊，现在想看看状态都看不了</span><span class="quote">闪电下课 2019-08-04 16:38:00 发表:<br>投稿后一般多久会给稿号啊，现在想看看状态都看不了</span>, beContent=闪电下课 2019-08-04 发表:: 投稿后一般多久会给稿号啊，现在想看看状态都看不了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KZBNgla4iaeV8NyshicxHNCqFLdAWkDAG0AxmdMCLxheE6jA9csvJ5fWqQ5ozqDNiclQbVyhOmxJNLyJxegeAloKA/0, createdBy=d2112162916, createdName=Liuying11, createdTime=Tue Feb 04 00:00:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101295, encodeId=1cf61101295a6, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101296, encodeId=492f1101296e5, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002391, encodeId=35d61002391c8, content=审稿速度:6.0<br>偏重的研究方向：肿瘤<br>经验分享：从提交到一审意见回来经历了4个多月，四个审稿人，两个小修两个大修，结果编辑给的意见是拒稿，说我按照意见修改好之后欢迎我再重投。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1885490244, createdName=ms6000001325372637, createdTime=Sat Jul 24 21:48:35 CST 2021, time=2021-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969175, encodeId=c78a9691e5fe, content=请问单基因的生信无验证可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Fri May 28 12:10:13 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000901, encodeId=bdd31000901e0, content=偏重的研究方向： 肿瘤 <br>经验分享：3月26后投稿，6月15日小修，6月26日修回，7月18号接收，感觉还挺好的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a47a5258909, createdName=147fa11bm80暂无昵称, createdTime=Mon Jul 19 15:19:19 CST 2021, time=2021-07-19, status=1, ipAttribution=)]
    2021-07-19 147fa11bm80暂无昵称

    偏重的研究方向： 肿瘤
    经验分享：3月26后投稿，6月15日小修，6月26日修回，7月18号接收，感觉还挺好的

    0

共104条页码: 1/11页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map